Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST)
Condition: HIV-Infected Individuals Intervention: Biological: DD HST-NEETs Sponsor: Catherine Bollard Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials